Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
domingo, octubre 04
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
TG Therapeutics Inc
TGTX
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$54.29
0.67
1.25%
Últ. Act.: Oct 2, 5:03 PM
$54.00
0.38
0.71%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Finanzas
Sentimiento
Comparar
Opciones
Informe de acciones
Privacy Manager
TG Therapeutics Analyst Price Targets - Benzinga
TG Therapeutics Analyst Price Targets
Wall Street analyst price targets and consensus rating for TG Therapeutics (TGTX).
Analyst Ratings News
PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $78 price target.
Benzinga Newsdesk
PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72
JP Morgan analyst Brian Cheng maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and raises the price target from $65 to $72.
Benzinga Newsdesk
PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86
B. Riley Securities analyst William Woods maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $55 to $86.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77
HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $70 to $77.
Benzinga Newsdesk
PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20
B of A Securities analyst Alec Stranahan maintains TG Therapeutics (NASDAQ:TGTX) with a Underperform and raises the price target from $17 to $20.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $70 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $70 price target.
Benzinga Newsdesk
Crear lista de seguimiento
GRATIS: Haz un seguimiento de acciones y criptomonedas con las mejores alertas de Internet
Haz clic para comenzar
People Also Watch
AbbVie Inc
NYSE:ABBV
$263.04
0.08%
Amgen Inc
NASDAQ:AMGN
$404
0.24%
Gilead Sciences Inc
NASDAQ:GILD
$144.91
0.12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
$504.73
-%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
$736.5
0.18%
Moderna Inc
NASDAQ:MRNA
$189.64
-0.19%
Natera Inc
NASDAQ:NTRA
$410.35
-%
argenx SE
NASDAQ:ARGX
$919.21
-%
Revolution Medicines Inc
NASDAQ:RVMD
$206.25
-0.19%
BeOne Medicines Ltd
NASDAQ:ONC
$351.99
-1.7%
Muestra todas las empresas relacionadas con 10
